Search research articles
Contact Us
Filters
Showing results (31-40 of 100) with videos related to
Page
of 10
Sort By:
Cancer Research
|
October 6, 2005
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma
Siwen Hu-Lieskovan, Jeremy D Heidel, Derek W Bartlett, et al.
Future Oncology (London, England)
|
January 21, 2021
Addressing resistance to immune checkpoint inhibitor therapy: an urgent unmet need
Siwen Hu-Lieskovan, Gabriel G Malouf, Ira Jacobs, et al.
Japanese Journal of Infectious Diseases
|
September 23, 2011
CD4+CD38+HLA-DR+ cells: a predictor of viral set point in Chinese men with primary HIV infection who have sex with men
Zining Zhang, Siwen Hu, Jing Liu, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?
Charlene M Fares, Eliezer M Van Allen, Charles G Drake, et al.
Microbial Ecology
|
May 31, 2022
Lower Compositional Variation and Higher Network Complexity of Rhizosphere Bacterial Community in Constructed Wetland Compared to Natural Wetland
Siwen Hu, Rujia He, Jin Zeng, et al.
The Science of the Total Environment
|
April 20, 2024
Effects of different emergent macrophytes on methane flux and rhizosphere microbial communities in wetlands
Qisheng Li, Hongyang Deng, Rujia He, et al.
The Science of the Total Environment
|
October 3, 2022
Cumulative ecosystem response to Hydraulic Engineering Infrastructure Projects in an arid basin
Jing Wang, Lianqing Xue, Liyong Zhou, et al.
Journal for Immunotherapy of Cancer
|
April 18, 2019
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
Jasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 4, 2025
PD-L1 targeted antibody-polymer-Epirubicin conjugate prolongs survival in a preclinical murine model of advanced ovarian cancer
Jiahui Li, Hasan Al Faruque, Shannuo Li, et al.
BMC Cancer
|
May 6, 2015
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition
Stephen Mok, Jennifer Tsoi, Richard C Koya, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 100) with videos related to
Sort By:
Page
of 10
Cancer Research
|
October 6, 2005
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma
Siwen Hu-Lieskovan, Jeremy D Heidel, Derek W Bartlett, et al.
Future Oncology (London, England)
|
January 21, 2021
Addressing resistance to immune checkpoint inhibitor therapy: an urgent unmet need
Siwen Hu-Lieskovan, Gabriel G Malouf, Ira Jacobs, et al.
Japanese Journal of Infectious Diseases
|
September 23, 2011
CD4+CD38+HLA-DR+ cells: a predictor of viral set point in Chinese men with primary HIV infection who have sex with men
Zining Zhang, Siwen Hu, Jing Liu, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?
Charlene M Fares, Eliezer M Van Allen, Charles G Drake, et al.
Microbial Ecology
|
May 31, 2022
Lower Compositional Variation and Higher Network Complexity of Rhizosphere Bacterial Community in Constructed Wetland Compared to Natural Wetland
Siwen Hu, Rujia He, Jin Zeng, et al.
The Science of the Total Environment
|
April 20, 2024
Effects of different emergent macrophytes on methane flux and rhizosphere microbial communities in wetlands
Qisheng Li, Hongyang Deng, Rujia He, et al.
The Science of the Total Environment
|
October 3, 2022
Cumulative ecosystem response to Hydraulic Engineering Infrastructure Projects in an arid basin
Jing Wang, Lianqing Xue, Liyong Zhou, et al.
Journal for Immunotherapy of Cancer
|
April 18, 2019
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
Jasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 4, 2025
PD-L1 targeted antibody-polymer-Epirubicin conjugate prolongs survival in a preclinical murine model of advanced ovarian cancer
Jiahui Li, Hasan Al Faruque, Shannuo Li, et al.
BMC Cancer
|
May 6, 2015
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition
Stephen Mok, Jennifer Tsoi, Richard C Koya, et al.
Page
of 10